Struggle with migraines?
Learn about a new, no cost research study in the potential prevention of Migraine in adult participants with Episodic Migraine
Struggle with migraines?
Learn about a new, no cost research study
in the potential prevention of Migraine in adults
with Episodic Migraine
Over 36 million in the United States live with migraines. Migraine is the third most common and the seventh most disabling medical disorder in the world.1 An investigation is being conducted on the effectiveness of botulinum toxin as a preventative treatment for Episodic Migraine (6-14 migraine attacks per month).
You will receive study-related care and if eligible, receive compensation for your participation in the phase 3 clinical trial.
If you have headaches of moderate or severe intensity 6 to 14 times a month, you may suffer from Episodic Migraine. If you’re struggling with migraine, you may qualify for a new phase 3 research study, now being offered at select centers throughout 9 countries.
About the Study
Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. Migraine can be further categorized according to the frequency of attacks as Episodic Migraine (6-14 times a month) or Chronic Migraine (15 or more times a month). This study will assess the effects of an investigational study drug in preventing migraine in adult participants with Episodic Migraine.
Botulinum toxin is being developed for the prevention of migraine in adults with Episodic Migraine. Participants will be enrolled in 3 different treatment groups. There is 1 in 3 chance that participants will be assigned to receive placebo. Approximately 777 adult participants with Episodic Migraine will be enrolled in approximately 125 sites across the world.
Participants will attend regular visits with a local medical clinic at no cost. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires. Eligible participants will be compensated for time and travel.
Why Participate?
If you’re struggling with Episodic Migraine (6-14 migraine attacks a month), you may qualify for a new phase 3 research study, now being offered at select centers throughout the world. This study will assess the effects of an investigational study drug in preventing migraine in adult participants with Episodic Migraine. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.
No-cost Study Care
You will receive study-related care from experienced doctors, nurses, and research staff.
Exams
The study will include blood and urine tests and visits with a trained investigator.
Compensation
You might be eligible to receive compensation for your time and travel.
Fill out the form below to find out if you are eligible
- https://americanmigrainefoundation.org/resource-library/migraine-where-we-are-and-where-we-are-going/
© 2022 Accelerate Recruitment | Privacy Policy | Legal Notice
